Autopsy report · NCT00869869
Melatonin Supplementation to Improve Sleep in Patients With Heart Failure
Cause of deathSlow enrollment, also funding or business
“No subjects were enrolled in this study. Funding ran out.”
Life of this trial
- Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.
Vital statistics
- Status
- Withdrawn
- Phase
- Phase 2
- Sponsor
- Brigham and Women's Hospital
- Sponsor type
- University, hospital or other
- Conditions
- Heart Failure; Sleep Disorders
- Interventions
- melatonin; placebo
- Participants
- 0
- Sites
- 1
- Countries
- United States
Trials that died the same way
- ITT-5 Mechanisms of Spermatogenesis in Man
“No funding was obtained for this study.” - A Phase II Study of Ziv-aflibercept in Combination With Capecitabine/Oxaliplatin (XELOX) Chemotherapy in the Front-Line Treatment of Patients With Metastatic Colorectal Cancer
“Funding for the study was withdrawn, no participants were ever recruited.” - CBD for Pain Reduction and Opioid Use After Ankle and Tibia Fracture ORIF
“there was no funding to begin the study” - Assessing Respiratory Variability During Mechanical Ventilation in Acute Lung Injury (ALI)
“No participants were enrolled, no funding obtained to perform study” - Impact of Nutrition and Swallowing Function of Head and Neck Cancer Patients During the Course of Treatment
“The study did not receive funding.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.